Roche is positioning Genentech for sale.

anonymous

Guest
Roche is reorganizing Genentech for sale in the near future. The intention is to trim it down to improve its income statement by improving its P/L ratio. Do not shoot the messenger.
 

<







Roche is reorganizing Genentech for sale in the near future. The intention is to trim it down to improve its income statement by improving its P/L ratio. Do not shoot the messenger.

interesting thought. Not sure many would view acquiring the assets as an expansion of their portfolio. Novartis has a major stake in Roche so who knows?
 




Roche is reorganizing Genentech for sale in the near future. The intention is to trim it down to improve its income statement by improving its P/L ratio. Do not shoot the messenger.

Hero of the stupid.

If you actually follow the markets and pharma stocks you would have an idea that now is not the time to sell.